Restless legs syndrome in Parkinson's disease and other neurodegenerative diseases of the central nervous system

Movement Disorders

Volumn 22, Issue SUPPL. 18, 2007, Pages

  Iranzo, Alex ^a   Comella, Cynthia L ^b   Santamaria, Joan ^a   Oertel, Wolfgang ^c  

^a HOSPITAL CLÍNIC   (Spain)

^b RUSH UNIVERSITY   (United States)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Autosomal dominant spinocerebellar ataxias; Dopaminergic system; Machado joseph disease; Neurodegenerative diseases; Parkinson's disease; Restless legs syndrome

Indexed keywords

CLONAZEPAM; DOPAMINE RECEPTOR STIMULATING AGENT;

ALZHEIMER DISEASE; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; CONFERENCE PAPER; CORTICOBASAL DEGENERATION; DISEASE ASSOCIATION; DISEASE COURSE; FRONTOTEMPORAL DEMENTIA; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUNTINGTON CHOREA; LIMB MOVEMENT; MACHADO JOSEPH DISEASE; MORBIDITY; MOTOR DYSFUNCTION; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RESTLESS LEGS SYNDROME; SHY DRAGER SYNDROME; TREATMENT OUTCOME;

HUMANS; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE; RESTLESS LEGS SYNDROME;

EID: 38049014465     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21600     Document Type: Conference Paper

References (60)

1. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the restless legs syndrome diagnosis and epidemiology work shop at the national Institutes of Health. Sleep Med 2003;4:101-119.
2. Paulus W, Trenkwalder C. Less is more: pathophysilogy of dopaminergic-therapy-related augmentation in restless legs syndrome. Lancet Neurol 2006;10:878-886.
3. Langston JW. The Parkinson's complex: Parkinsonism is just the tip of the iceberg. Ann Neurol 2006;59:591-596.
4. Garcia-Borreguero D, Odin P, Serrano C. Restless legs syndrome and PD. A review of the evidence for a possible association. Neurology 2003;61 (Suppl 3):S49-S55.
5. Poewe W, Högl B. Akathisia, restless legs and periodic limb movements in sleep in Parkinson's disease. Neurology 2004;63 (Suppl 3):S12-S16.
6. Tan EK. Restless legs syndrome and Parkinson's disease: is there an etiological link? J Neurol 2006;253 (Suppl 7):33-37.
7. Ondo WG, Dat Vuong K, Jankovic J. Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol 2002;59:421-424.
8. Adel S, Djarmati A, Kabakci K, et al. Co-occurrence of restless legs syndrome and Parkin mutations in two families. Ann Neurol 2006;21:258-263.
9. Comella CL. Restless legs syndrome: treatment with dopaminergic agents. Neurology 2002;58 (Suppl 1):S87-S92.
10. Jellinger KA. Post mortem studies in Parkinson's disease. Is it possible to detect brain areas for specific symptoms? J Neural Transm 1999;56 (Suppl):1-29.
11. Connor JR, Boyer PJ, Menzies SL, et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 2003;61:304-309.
12. Pittock SJ, Parret T, Adler CH, Parisi JE, Dickson DW, Ahlskog JE. Neuropathology of primary restless legs syndrome: absence of specific tau and alpha-synuclein pathology. Mov Disord 2004;19:695-699.
13. Allen RP, Barker PB, Wehrl F, Song HK, Earley CJ. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 2001;56:263-265.
14. Schmidauer C, Sojer M, Seppi K, et al. Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome. Ann Neurol 2005;58:630-634.
15. Linke R, Eisensehr I, Wetter TC, et al. Presynaptic dopaminergic function in patients with restless legs syndrome: are there common features with early Parkinson's disease? Mov Disord 2004;19:1158-1162.
16. Walters AS, LeBrocq C, Passi V, et al. A preliminary look at the percentage of patients with restless legs syndrome who also have Parkinson's disease, essential tremor or Tourette syndrome in a single practice. J Sleep Res 2003;12:343-345.
17. Clemens S, Rye D, Hochman S. Restless legs syndrome. Revisiting the dopamine hypothesis from the spinal cord perspective. Neurology 2006;67:125-130.
18. Zhao H, Zhu W, Pan T, et al. Spinal cord dopamine receptor expression and function in mice with 6-OHDA lesion of the All nucleus and dietary iron deprivation. J Neurosci Res 2007;15:1065-1076.
19. Wetter TC, Collado-Seidel V, Pollmächer T, Yassouridis A. Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease and multiple system atrophy. Sleep 2000;23:361-367.
20. Iranzo A, Santamaría J, Rye DB, et al. Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD. Neurology 2005;65:247-252.
21. Kumru H, Santamaría J, Tolosa E, et al. Rapid eye movement sleep behavior disorder in parkinsonism with PARKIN mutations. Ann Neurol 2004;56:599-603.
22. Ancoli-Israel S, Kripke DF, Klauber MR, Mason WJ, Fell R, Kaplan O. Periodic limb movements in sleep in community-dwelling elderly. Sleep 1991;14:496-500.
23. Happe S, Pirke W, Klösch G, Sauter C, Zeitlhofer J. Periodic leg movements in patients with Parkinson's disease are associated with reduced striatal dopamine transporter binding. J Neurol 2003;250:83-86.
24. Iranzo A, Valldeoriola F, Santamaría J, Tolosa E. Rumià J. Sleep symptoms and polysomnographic architecture in advanced Parkinson's disease after chronic bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002;72:661-664.
25. Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Neurology 2000;54:1064-1068.
26. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000;160:2137-2141.
27. Tison F, Crochard A, Léger D, Boueé S, Lainey E, El Hasnaoui A. Epidemiology of restless legs syndrome in French adults. A national survey. The INSTANT study. Neurology 2005;65:239-246.
28. Allen RP, Walters AS, Montplaisir J. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 2005;165:1286-1292.
29. Garcia-Borreguero D, Egatz R, Winkelmann J. Epidemiology of restless legs syndrome: the current status. Sleep Med Rev 2006;10:153-167.
30. de Lau LML, Breteler MMB. Epidemiology of Parkinson's disease. Lancet Neurol 2006;5:525-535.
31. Kedia S, Moro E, Tagliati M, Lang AE, Kumar R. Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease. Neurology 2004;63:2410-2412.
32. Driver-Dunckley E, Evidente VGH, Adler CH, et al. Restless legs syndrome in Parkinson's disease patients may improve with subthalamic stimulation. Mov Disord 2006;21:1287-1289.
33. Lang AE, Johnson K. Akathisia in idiopathic Parkinson's disease. Neurology 1987;37:477-481.
34. Khan SA, Sahota PK. A study look for the incidence of restless legs syndrome in patients with Parkinson's disease. Sleep 2002;25 (Suppl):A378-A379.
35. Tan EK, Lum SY, Wong MC. Restless legs syndrome in Parkinson's disease. J Neurol Sci 2002;196:33-36.
36. Krishnan PR, Bhatia M, Behari M. Restless legs syndrome in Parkinson's disease: a case-controlled study. Mov Disord 2003;18:181-185.
37. Braga-Neto P, Silva-Júnior FP, Monte FS, de Bruin PFC, de Bruin VMS. Snoring and excessive daytime sleepiness in Parkinson's disease. J Neurol Sci 2004;217:41-45.
38. Peralta CM, Wolf E, Seppi K, Wenning GK, Hogl B, Poewe W. Restless legs in idiopathic Parkinson's disease. Mov Disord 2005;20 (Suppl 10):S108.
39. Nomura T, Inoue Y, Miyake M, Yasui K, Nakashima K. Prevalence and clinical characteristics of restless legs syndrome in Japanese patients with Parkinson's disease. Mov Disord 2006;21:380-384.
40. Iranzo A. Exploring the relationship between Parkinson disease and restless legs syndrome. Sleep Med 2003;4:161-162.
41. Nomura T, Inoue Y, Nakashima K. Clinical characteristics of restless legs syndrome patients with Parkinson's disease. J Neurol Sci 2006;250:39-44.
42. Klockgether T. Hereditary ataxias. In: Jankovic J, Tolosa E, editors. Parkinson's disease and movement disorders. Lippincott Williams & Wilkms: Philadelphia: 2007. p 421-435.
43. Schöls L, Haan J, Riess O, Amoiridis A, Przuntek H. Sleep disturbances in spinocerebellar ataxias. Is the SCA3 mutation a cause of restless legs syndrome? Neurology 1998;51:1603-1607.
44. Abele N, Bürk K, Laccone F, Dichgans J, Klockgether T. Restless legs syndrome in spinocerebellar ataxias types 1,2 and 3. J Neurol 2001;248:311-314.
45. Van Alfen N, Sinke RJ, Zwarts MJ, et al. Intermediate CAG repeat lengths (53,54) for MJD/SCA3 are associated with an abnormal phenotype. Ann Neurol 2001;49:805-808.
46. Iranzo A, Muñoz E, Santamaría J, Vilaseca I, Milà M. Tolosa E. REM sleep behavior disorder and vocal cord paralysis in Machado-Joseph disease. Mov Disord 2003;18:1179-1183.
47. Boesch SM, Frauscher B, Brandauer E, Wenning GK, Högl B, Poewe P. Restless legs syndrome and motor activity during sleep in spinocerebellar ataxia type 6. Sleep Med 2006;7:529-532.
48. Boesch SM, Frauscher B, Brandauer E, Wenning GK, Högl B, Poewe P. Disturbance of rapid eye movement sleep in spinocerebellar ataxia type 2. Mov Disord 2006;21:1751-1754.
49. 11C] raclopride positron emission tomography. Mov Disord 2006;10:1667-1673.
50. Konieczny M, Bauer P, Tomiuk J, et al. CAG repeats in restless legs syndrome. Am J Med Genet B Neuropsychiatr Genet 2006;141:173-176.
51. Desautels A, Turecki G, Montplaisir J, at al. Analysis of CAG repeat expansions in restless legs syndrome. Sleep 2003;26:1055-1057.
52. Yen TC, Lu CS, Tzen KY, et al. Decreased dopamine transporter binding in Machado-Joseph disease. J Nucl Med 2000;41:994-998.
53. Taniwaki T, Sakai T, Kobayashi T, et al. Positron emission tomography (PET) in Machado-Joseph disease. J Neurol Sci 1997;145:63-67.
54. Tuite PJ, Rogaeva ES, St George-Hyslop PH, Land AE. Dopa responsive parkinsonism phenotype of Machado-Joseph disease: confirmation of 14q CAG expansion. Ann Neurol 1995;38:684-687.
55. Kahn NL, Giunti P, Sweeney MG, et al. Parkinsonism and nigrostriatal dysfunction are associated with spinocerebellar ataxia type (SCA6). Mov Disord 2005;20:115-119.
56. Lu CS, Wu Chou YH, Yen TC, Tsai CH, Chen RS, Chang HC. Dopa-responsive parkinsonism phenotype of spinocerebellar ataxia type 2. Mov Disord 2002;17:1046-1051.
57. Wilkins A, Brown JM, Barker RA. SCA2 presenting as levodoparesponsive parkinsonism in a young patientfrom the United Kingdom: a case report. Mov Disord 2004;19:593-595.
58. Wullner U, Reimold M, Abele M, et al. Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1,2,3, and 6. Arch Neurol 2005;62:1280-1285.
59. Evers S, Stögbauer F. Genetic association of Huntington's disease and restless legs syndrome? A family report. Mov Disord 2003;18:225-227.
60. Sperfeld AD, Unrath A, Kassubek J. Restless legs syndrome in hereditary spastic paraparesis. Eur Neurol 2007;57:31-35.